ERT-Bioclinica marriage, led by Nordic and Astorg, pushes valuation to $5.9bn

The merger of the clinical trial technology companies comes as CROs and the broader pharma industry face growing pressure to shift to a cloud-based approach to speed up decision-making in drug development.